Endexx Launches First Transparent Pilot and Testing Program for Medical Marijuana Dispensing With Autospense for High Security and Tracking
CAVE CREEK, AZ--(Marketwired - Dec 1, 2014) - Endexx Corporation (
Michael Quattrone of Pure Medical Dispensary stated, "In order to maintain top level quality control, transparency and compliance standards in this ever changing market, technology integration is key to sustainability and success. Endexx provides us a professional technology solution and a team that clearly has an objective to help set the standards for our industry. We are excited to participate in this critical and necessary pilot program."
Endexx's Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details, monitoring and tracking of inventory, and provides verification and safety for the product, as well as patients and customers of the dispensary. Autospense™ increases store productivity up to 10x and reduces operation costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers and provides patients and customers an option to make rapid purchases when they know what they want and are short on time.
"Lack of transparency and compliance can make dispensary owners vulnerable," said Todd Davis, Founder and CEO of Endexx Corporation. "Regulatory compliance is essential for the long term sustainability of both the medical and retail marijuana markets. Autospense™ is ideal for any dispensary and offers a cutting-edge solution that maintains full compliance and has the ability to adapt with changing regulations. After extensively evaluating the barriers to adoption in an often-uncertain regulatory environment, Endexx chose to seek the most transparent and legal route before launching its product lines. Collaborating with a proven leader in the medical cannabis industry, Pure's management team has offered us the perfect environment to execute our mission and test our compliance platform."
Endexx provides innovative medical marijuana management and technology solutions. The company has two products that launched in 2014 -- the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through "seed to sale" inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of State government and local regulatory bodies, as well as, provide a smooth transition to the eventual Federal mandates. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. www.endexx.com, www.m3hub.com, www.autospense.com
Safe Harbor Notice
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
For further investor and media information, contact:
Chairman & CEO